An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Medical weight loss in Sacramento

Since January 1, 2026, Medi-Cal no longer covers GLP-1 drugs for weight loss in adults, so many Sacramento patients now pay cash [1]. On Oct 17, 2026, the makers' prices ran from $149 a month for the lowest-dose Wegovy pill up to $449 for the higher Zepbound doses [2] [3].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Medical weight loss is obesity care supervised by a licensed prescriber, which may include FDA-approved weight medicines and regular follow-up.

Medi-Cal, adults
GLP-1 weight loss coverage ended Jan 1, 2026 [1]
Adult obesity, Sacramento
30.0% (2023) [4]
Diagnosed diabetes, Sacramento County
11.2% [5]
Population
536,449 (July 1, 2025) [6]

Compare online GLP-1 programs

What the Medi-Cal change means in Sacramento

California's 2025 to 2026 budget ended Medi-Cal coverage of GLP-1 drugs for adult weight loss effective January 1, 2026. Members under 21 are still covered, and GLP-1s prescribed for other conditions can be covered when medically necessary [1]. KFF lists California among four states that dropped obesity coverage after October 2025 [7].

The change lands on a large group. CDC PLACES estimates that 30.0% of Sacramento adults had obesity in 2023, and 11.2% had diagnosed diabetes [4]. The city had 536,449 residents in mid-2025 [6].

Sponsored practices pay for this slot. The label is there so you know it is advertising, not advice.

Cash prices that replaced coverage

What Sacramento patients pay the drug makers (prices as of Oct 17, 2026)
Medicine and sellerPer monthDetails
Wegovy pill from NovoCare$149 to $299 [2]$149 for 1.5 mg, $199 for 4 mg, $299 for 9 and 25 mg
Foundayo pill from LillyDirect$149 to $299 [8]Goes up with the dose
Wegovy pen from NovoCare$349 [2]Covers the 0.25 to 2.4 mg pens
Zepbound from LillyDirect$299 to $449 [3]Higher regular price when a refill is late
Medicine only, before a Sacramento clinic's fees. Other channels and add-on costs: GLP-1 cost guide.

Both daily tablets, the Wegovy pill and Lilly's Foundayo, open at $149 a month [2] [8]. Those are starting strengths, so the bill climbs as the dose is raised. Pill versus pill: Foundayo vs Wegovy pill.

Coverage that still exists

  • Medi-Cal members under 21: weight loss coverage continues [1], and the Wegovy injection is approved from age 12 [9].
  • Medi-Cal and type 2 diabetes: uses other than weight loss can still be paid for when medically necessary [1].
  • Medicare Part D: through December 31, 2027, the GLP-1 Bridge charges a $50 copay for the Zepbound KwikPen, Foundayo or Wegovy if you meet its BMI and health rules [10] [11].
  • Job-based insurance: read the formulary. When the plan covers the drug, Wegovy and Zepbound savings offers can cut the cost to $25 [2] [12].

Choosing a Sacramento prescriber

The Medical Board of California runs a public license search for physicians [13]. A cheap compounded semaglutide or tirzepatide offer deserves caution: compounded versions lack FDA approval, and FDA does not judge their safety, effectiveness or quality [14]. Screen with our clinic checklist and FDA warning letter tracker. Sacramento drug pages: tirzepatide and semaglutide.

Up and down the West Coast: San Francisco, San Jose, Los Angeles and Seattle. Main guide: weight loss.

Safety warnings

Read before starting

Thyroid C-cell tumors in rodents led to a boxed warning; skip these drugs if you have MEN 2 or if you or anyone in your family has had medullary thyroid carcinoma. Lasting, severe pain in the abdomen may be pancreatitis. Sulfonylureas or insulin raise the odds of low blood sugar. Zepbound is stopped once pregnancy is recognized [15] [9]. Throat swelling or trouble breathing calls for 911.

Questions people ask

Does Medi-Cal still pay for weight loss drugs for Sacramento adults?

No. Medi-Cal ended coverage of GLP-1s for adult weight loss on January 1, 2026. Members under 21 keep coverage, and other medically necessary uses can be covered [1].

What does a month of medical weight loss drugs cost in Sacramento?

The brand drug alone ran $149 to $449 a month on Oct 17, 2026, from the Wegovy pill at $149 to Zepbound at up to $449 [2] [3]. Visits and labs cost extra.

Is obesity more common in the city of Sacramento or the county?

About the same. CDC PLACES estimates 30.0% of city adults and 29.6% of Sacramento County adults had obesity in 2023 [4] [5].

Can Sacramento Medicare members get Wegovy for $50?

Yes, if eligible. The GLP-1 Bridge runs July 1, 2026 to December 31, 2027 and covers Wegovy, Foundayo or the Zepbound KwikPen at $50 a month for Part D enrollees who qualify [10] [11].

How many Sacramento adults have diabetes?

CDC PLACES estimates 11.2% of adults in Sacramento had diagnosed diabetes in 2023 [4].

What did tirzepatide do in its first big obesity trial?

In SURMOUNT-1, adults without diabetes on tirzepatide 15 mg lost 20.9% of body weight on average at 72 weeks, compared with 3.1% on placebo [16].

Sources

16 cited
  1. California Medicaid ends coverage of GLP-1 weight loss drugs. KFF Health News, Jan 9, 2026.
  2. Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), accessed 2026-10-17.
  3. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
  4. PLACES place data: Sacramento, CA. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
  5. PLACES county data: Sacramento County, CA. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
  6. QuickFacts: Sacramento city, California. U.S. Census Bureau, QuickFacts, V2025; ACS 2020-2024.
  7. Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
  8. Foundayo self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
  9. Wegovy label. DailyMed, NLM, Jun 2026.
  10. Weight loss drugs coverage. Medicare.gov (CMS), accessed 2026-10-17.
  11. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
  12. Zepbound coverage and savings. Eli Lilly and Company, accessed 2026-10-17.
  13. Medical Board of California. Medical Board of California, accessed 2026-10-17.
  14. FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
  15. Zepbound prescribing information. US FDA (accessdata.fda.gov), Apr 2026.
  16. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare online GLP-1 programs